- Home
- RNA vs ATAT Comparison
RNA vs ATAT Comparison
Compare RNA & ATAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- ATAT
- Stock Information
- Founded
- RNA 2012
- ATAT 2013
- Country
- RNA United States
- ATAT China
- Employees
- RNA N/A
- ATAT N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- ATAT Hotels/Resorts
- Sector
- RNA Health Care
- ATAT Consumer Discretionary
- Exchange
- RNA Nasdaq
- ATAT Nasdaq
- Market Cap
- RNA 3.7B
- ATAT 3.8B
- IPO Year
- RNA 2020
- ATAT 2022
- Fundamental
- Price
- RNA $31.12
- ATAT $31.26
- Analyst Decision
- RNA Strong Buy
- ATAT Strong Buy
- Analyst Count
- RNA 10
- ATAT 2
- Target Price
- RNA $65.80
- ATAT $23.69
- AVG Volume (30 Days)
- RNA 1.3M
- ATAT 1.2M
- Earning Date
- RNA 03-07-2025
- ATAT 03-27-2025
- Dividend Yield
- RNA N/A
- ATAT 1.44%
- EPS Growth
- RNA N/A
- ATAT 162.91
- EPS
- RNA N/A
- ATAT 1.20
- Revenue
- RNA $10,117,000.00
- ATAT $950,764,843.00
- Revenue This Year
- RNA N/A
- ATAT $55.64
- Revenue Next Year
- RNA N/A
- ATAT $25.38
- P/E Ratio
- RNA N/A
- ATAT $26.66
- Revenue Growth
- RNA N/A
- ATAT 76.11
- 52 Week Low
- RNA $13.73
- ATAT $15.22
- 52 Week High
- RNA $56.00
- ATAT $33.32
- Technical
- Relative Strength Index (RSI)
- RNA 44.06
- ATAT 66.64
- Support Level
- RNA $31.14
- ATAT $31.01
- Resistance Level
- RNA $33.37
- ATAT $33.32
- Average True Range (ATR)
- RNA 1.67
- ATAT 1.44
- MACD
- RNA -0.16
- ATAT 0.41
- Stochastic Oscillator
- RNA 11.27
- ATAT 72.94
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
About ATAT Atour Lifestyle Holdings Limited
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.